| Patents for C07K 5 - Peptides having up to four amino acids in a fully defined sequence; Derivatives thereof (30,692) |
|---|
| 02/16/2011 | EP2284179A2 Inhibitors of cancer cell, T-cell and keratinocyte proliferation |
| 02/16/2011 | EP2284178A2 Inhibitors of cancer cell, T-cell and keratinocyte proliferation |
| 02/16/2011 | EP2283028A2 Vegfr-1/nrp-1 targeting peptides |
| 02/15/2011 | US7888468 Recombinant copper containing protein for use in prevention and treatment of cell proliferative dsorders and infection |
| 02/15/2011 | US7888291 Substrates and assays for β-secretase |
| 02/15/2011 | CA2633072C Analgesic compounds and process of manufacture |
| 02/15/2011 | CA2471723C Intermediates for lhrh antagonist synthesis, process for their production, and process for lhrh antagonist production |
| 02/15/2011 | CA2361364C Dalda analogs and their use |
| 02/15/2011 | CA2325937C Peptide turn mimetics |
| 02/15/2011 | CA2263647C Stable non-hygroscopic crystalline form of n-[n-n-(4-(piperidin-4-yl)butanoyl)-n-ethylglycyl] compounds |
| 02/15/2011 | CA2189691C Novel tetrapeptides, their preparation and use |
| 02/10/2011 | WO2011017249A1 Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof |
| 02/10/2011 | US20110034390 Peptides, compositions, and uses thereof |
| 02/10/2011 | US20110033560 Preparation and a component intended to be added to a tobacco product |
| 02/10/2011 | US20110033507 Polypeptides KXK and Their Use |
| 02/10/2011 | US20110033420 Macrocyclic compounds as hepatitis c virus inhibitors |
| 02/10/2011 | CA2770042A1 Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof |
| 02/09/2011 | EP2281006A1 Cross-linkers and their uses |
| 02/09/2011 | EP2038295B1 Pseudo proline dipeptides |
| 02/09/2011 | EP1931656B1 Novel drugs for dementia |
| 02/09/2011 | EP1370276B1 Intercellular communication facilitating compounds and their medical use |
| 02/09/2011 | CN1969046B Peptide substrates recognisable by a botulinum toxin A, BoNT/A and the use thereof |
| 02/09/2011 | CN101970459A Antimicrobial compounds |
| 02/09/2011 | CN101970458A Novel gamma-secretase inhibitor |
| 02/09/2011 | CN101970457A Inhibitors of iap |
| 02/09/2011 | CN101967183A Artificially synthesized novel antithrombotic peptide derivative, preparation method and application thereof |
| 02/09/2011 | CN101967182A Antimicrobial compound and preparation method and application thereof |
| 02/09/2011 | CN101967128A Benzo uracil PNA (Peptide Nucleic Acid) monomer and intermediate thereof as well as preparation methods and applications of benzo uracil PNA and intermediate thereof |
| 02/09/2011 | CN101967113A 3-alloc amido-3-(3- nitryl-4-fluorophenyl) propionic acid and preparation method thereof |
| 02/08/2011 | US7884184 comprises a peptide or polypeptide chain comprising at least a portion of an immunoglobulin constant or variable region; suppressing an antigen-specific immune response to a target antigen; Autoimmune disease |
| 02/08/2011 | US7884180 binds formyl peptide receptor-like 1 (FPRL1); useful for treating disorders associated with G-protein coupled receptor activation |
| 02/08/2011 | US7884067 Peptides derived from cadherin and methods of use thereof |
| 02/08/2011 | CA2494300C Growth hormone releasing peptides |
| 02/08/2011 | CA2431461C 1,5 benzothiazepines and their use as antihyperlipidemics |
| 02/03/2011 | WO2011014494A1 ENANTIO- AND STEREO-SPECIFIC SYNTHESES OF β-AMINO-α- HYDROXY AMIDES |
| 02/03/2011 | WO2011014487A1 Hepatitis c virus ns3 protease inhibitors |
| 02/03/2011 | WO2011013612A1 Peptidic compound and use of same |
| 02/03/2011 | WO2010144344A3 Melanocortin receptor-specific peptides |
| 02/03/2011 | WO2010144341A3 Lactam-bridged melanocortin receptor-specific peptides |
| 02/03/2011 | US20110028401 Cripto blocking molecules and therapeutic uses thereof |
| 02/03/2011 | US20110028397 Use of Urokinase Type Plasminogen Activator Inhibitors for the Treatment of Corneal Disorders |
| 02/03/2011 | US20110027274 Antiproliferative compounds, conjugates thereof, methods therefor, and uses thereof |
| 02/03/2011 | CA2768838A1 Enantio- and stereo-specific syntheses of beta-amino-alpha- hydroxy amides |
| 02/02/2011 | EP2280030A2 Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| 02/02/2011 | EP2280022A1 Cripto blocking molecules and therapeutic uses thereof |
| 02/02/2011 | EP2280016A1 New synthetic route for the preparation of alpha-amino boronic esters via substituted alk-1-ynes |
| 02/02/2011 | EP2279777A2 Compounds and compositions as channel activating protease inhibitors |
| 02/02/2011 | EP2279759A2 Compounds and methods for 18F labeled agents |
| 02/02/2011 | EP2279744A2 ApoE mimetic agents |
| 02/02/2011 | EP2279743A2 ApoE mimetic agents |
| 02/02/2011 | EP2279741A2 Caprolactams and their use as anti-inflammatory agents |
| 02/02/2011 | EP1664092B1 Macrocyclic inhibitors of hepatitis c virus ns3 serine protease |
| 02/02/2011 | EP1020179B9 Peptide derivatives or pharmaceutically acceptable salts thereof, method for producing the same, use of said derivatives and pharmaceutical composition |
| 02/02/2011 | CN101962400A Linear epitope minimum motif peptide of human papilloma virus type 58 L1 protein and application thereof |
| 02/02/2011 | CN101962349A 3-Boc amidocyanogen-3-(3-nitryl-4-fluorophenyl) monoprop and preparation method thereof |
| 02/02/2011 | CN101228179B A process for the preparation of perindopril erbumine |
| 02/02/2011 | CN101108876B Method for preparing S- protection glutathione by adopting complexation common protection |
| 02/01/2011 | US7879893 Zinc binding ligand; sustained release of insulin |
| 02/01/2011 | US7879609 Regulatory segments of the human gene for telomerase reverse transcriptase |
| 02/01/2011 | US7879335 Glycoconjugates, glycoamino acids, intermediates thereto, and uses thereof |
| 02/01/2011 | CA2485941C Production of crystalline materials by using high intensity ultrasound |
| 01/27/2011 | WO2010122423A3 Peptide compositions |
| 01/27/2011 | WO2010041150A3 Pharmaceutical peptides for the treatment of inflammatory diseases |
| 01/27/2011 | US20110021438 Novel compounds of the n-acylamino-amide family, compositions comprising them and uses thereof |
| 01/27/2011 | US20110021434 Macrocyclic Cysteine Protease Inhibitors and Compositions Thereof |
| 01/27/2011 | US20110020335 Treatment of Cancers Expressing p95 ErbB2 |
| 01/26/2011 | EP1913014B1 Macrocyclic inhibitors of hepatitis c virus |
| 01/26/2011 | EP1303186B1 Medicinal uses of mu-opioid receptor agonists |
| 01/26/2011 | EP1179004B1 Potassium channel kcnq5 |
| 01/26/2011 | CN101955510A Affinity peptide specific to herceptin and segment thereof |
| 01/26/2011 | CN101955509A Method for extracting glutathione from saccharomycetes |
| 01/26/2011 | CN101172997B Oligopeptide or its modified compound/derivant and application thereof |
| 01/26/2011 | CN101077875B Boronic ester and acid compounds, synthesis and uses |
| 01/25/2011 | US7875436 immobilization; solid phase synthesis; kits |
| 01/25/2011 | CA2426692C Block copolymers for multifunctional self-assembled systems |
| 01/25/2011 | CA2385322C A substantially cell membrane impermeable compound and use thereof |
| 01/25/2011 | CA2382931C Synthesis of template-fixed .beta.-hairpin loop mimetics |
| 01/22/2011 | CA2710693A1 Pharmaceutical compositions |
| 01/20/2011 | WO2011007612A1 Anti-inflammatory agent for oral application, and anti-inflammatory peptide for oral application |
| 01/20/2011 | US20110015372 Methods and compositions for improved uptake of biological molecules |
| 01/20/2011 | US20110015371 Inhibitors of interleukin-1 beta converting enzyme |
| 01/20/2011 | US20110015344 Biodegradable polyacetals for in vivo polynucleotide delivery |
| 01/19/2011 | EP2275401A1 Crystalline 1-{[(a-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane acetic acid |
| 01/19/2011 | EP2275138A1 Promoter for bicarbonate secretion in gastrointestinal tract |
| 01/19/2011 | EP2274002A2 Leucine-rich peptide compositions and methods for isolation |
| 01/19/2011 | EP1802649B1 Solid phase peptide sythesis |
| 01/19/2011 | EP1781688B1 Compounds for proteasome enzyme inhibition |
| 01/19/2011 | EP1411962B1 Monoclonal antibody therapy for pancreas cancer |
| 01/19/2011 | CN101948507A Novel anti-cancer medicaments using NGR(NO2) as targeting carrier, preparation thereof and use thereof |
| 01/19/2011 | CN101948506A Finasteride conjugate and application thereof to preparation of medicament for treating prostate |
| 01/18/2011 | US7872096 ligating recombinant intein domains to a linear synthetic protein to form a compound D1-X(n)-D2, where D1 and D2 are catalytic domains of an intein and X is a protein; cell-free; producing small cyclic peptides containing non-genetically encodable amino acids; for drugs |
| 01/18/2011 | US7871998 Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity |
| 01/18/2011 | US7871786 Isolated nucleic acid encoding GEF-H1b polypeptide (Guanine nucleotide exchange factors); diagnosing abnormal cell proliferation and drug screening; measuring phosphorylation by p-21 activated kinase; antitumor agents, anticancer agents |
| 01/18/2011 | US7871767 Polymorphisms in the human gene for cytochrome P450 polypeptide 2C8 and their use in diagnostic applications |
| 01/18/2011 | CA2425445C Tetrapeptide stimulating functional activity of hepatocytes, pharmacological substance on its basis and the method of its application |
| 01/18/2011 | CA2408501C Melphalan derivatives and their use as cancer chemotherapeutic drugs |
| 01/13/2011 | WO2009032477A3 Vegfr-1/nrp-1 targeting peptides |
| 01/13/2011 | US20110009311 Peptides and their utility in modulation of behavior of cells expressing alpha3 beta1 integrins |
| 01/13/2011 | DE102009032902A1 Induktion von α-Helix-Konformationen in Proteinen und Peptiden Induction of α-helical conformations in proteins and peptides |
| 01/12/2011 | EP2272858A2 HCV inhibitors comprising beta amino acids and their uses |